메뉴 건너뛰기




Volumn 74, Issue 1, 2014, Pages 93-94

Rituximab decreases without preference all subclasses of IgG anti-BP180 autoantibodies in refractory bullous pemphigoid (BP)

Author keywords

Auto antibodies: IgG subclass; Bullous pemphigoid; Rituximab

Indexed keywords

AUTOANTIBODY; COLLAGEN ANTIBODY; COLLAGEN TYPE 12; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; RITUXIMAB; ANTIRHEUMATIC AGENT; AUTOANTIGEN; COLLAGEN TYPE 17; MONOCLONAL ANTIBODY; NONFIBRILLAR COLLAGEN;

EID: 84895930657     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.11.014     Document Type: Letter
Times cited : (11)

References (10)
  • 1
    • 0027487314 scopus 로고
    • Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain
    • Giudice G.J., Emery D.J., Zelickson B.D., Anhalt G.J., Liu Z., Diaz L.A. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol 1993, 151:5742-5750.
    • (1993) J Immunol , vol.151 , pp. 5742-5750
    • Giudice, G.J.1    Emery, D.J.2    Zelickson, B.D.3    Anhalt, G.J.4    Liu, Z.5    Diaz, L.A.6
  • 2
    • 0030724110 scopus 로고    scopus 로고
    • A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid
    • Zillikens D., Mascaro J.M., Rose P.A., Liu Z., Ewing S.M., Caux F., et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997, 109:679-683.
    • (1997) J Invest Dermatol , vol.109 , pp. 679-683
    • Zillikens, D.1    Mascaro, J.M.2    Rose, P.A.3    Liu, Z.4    Ewing, S.M.5    Caux, F.6
  • 3
    • 0033964612 scopus 로고    scopus 로고
    • Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid
    • Schmidt E., Obe K., Brocker E.B., Zillikens D. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000, 136:174-178.
    • (2000) Arch Dermatol , vol.136 , pp. 174-178
    • Schmidt, E.1    Obe, K.2    Brocker, E.B.3    Zillikens, D.4
  • 5
    • 0035034812 scopus 로고    scopus 로고
    • Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses
    • Laffitte E., Skaria M., Jaunin F., Tamm K., Saurat J.H., Favre B., et al. Autoantibodies to the extracellular and intracellular domain of bullous pemphigoid 180, the putative key autoantigen in bullous pemphigoid, belong predominantly to the IgG1 and IgG4 subclasses. Br J Dermatol 2001, 144:760-768.
    • (2001) Br J Dermatol , vol.144 , pp. 760-768
    • Laffitte, E.1    Skaria, M.2    Jaunin, F.3    Tamm, K.4    Saurat, J.H.5    Favre, B.6
  • 6
    • 33846204327 scopus 로고    scopus 로고
    • Rituximab in autoimmune bullous diseases: mixed responses and adverse effects
    • Schmidt E., Seitz C.S., Benoit S., Brocker E.B., Goebeler M. Rituximab in autoimmune bullous diseases: mixed responses and adverse effects. Br J Dermatol 2007, 156:352-356.
    • (2007) Br J Dermatol , vol.156 , pp. 352-356
    • Schmidt, E.1    Seitz, C.S.2    Benoit, S.3    Brocker, E.B.4    Goebeler, M.5
  • 10
    • 84887822290 scopus 로고    scopus 로고
    • Association of serum B cell activating factor (BAFF) level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients
    • [advanced online publication 27 June 2013]
    • Hall R.P., Streilein R.D., Hannah D., McNair P., Fairley J.A., Ronaghy A., et al. Association of serum B cell activating factor (BAFF) level and proportion of memory and transitional B cells with clinical response after rituximab treatment of bullous pemphigoid patients. J Invest Dermatol 2013, [advanced online publication 27 June 2013]. 10.1038/jid.2013.236.
    • (2013) J Invest Dermatol
    • Hall, R.P.1    Streilein, R.D.2    Hannah, D.3    McNair, P.4    Fairley, J.A.5    Ronaghy, A.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.